SCHEMBL19655291

SCHEMBL19655291

c1ccc2nc(-n3c4ccccc4c4cc5c(cc43)c3ccccc3n5-c3cccc4c3sc3ccccc34)cnc2c1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.34
SMN1; SMN2 Q16637 3/20 0.34
NFKB1 P19838 2/20 0.34
NFKB2 Q00653 2/20 0.34
RELA Q04206 2/20 0.34
LMNA P02545 2/20 0.34
NPSR1 Q6W5P4 1/20 0.34
ALOX5 P09917 1/20 0.32
NPC1 O15118 3/20 0.32
RAB9A P51151 3/20 0.32
ALDH1A1 P00352 2/20 0.32
HPGD P15428 2/20 0.32
HTR3A P46098 1/20 0.32
HRH4 Q9H3N8 1/20 0.32
GAA P10253 1/20 0.32
HTT P42858 1/20 0.32
KDM4E B2RXH2 1/20 0.30
TP53 P04637 1/20 0.30
HSD17B10 Q99714 1/20 0.30
PDE10A Q9Y233 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19655177 0.88 SMN1; SMN2 (0.34) MAPTSMN1; SMN2NFKB1NFKB2RELA
SCHEMBL19655347 0.86 ALOX5 (0.32) MAPTALOX5
SCHEMBL19655149 0.84 ALOX5 (0.33) ALOX5
SCHEMBL15582935 0.83 ALOX5 (0.42) MAPTSMN1; SMN2ALOX5RAB9AALDH1A1
SCHEMBL19655304 0.83 MAPT (0.39) MAPTSMN1; SMN2NFKB1NFKB2RELA
SCHEMBL19655135 0.82 NPC1 (0.43) MAPTSMN1; SMN2NFKB1NFKB2RELA
SCHEMBL17206511 0.80 ALOX5 (0.40) MAPTSMN1; SMN2ALOX5RAB9AALDH1A1
SCHEMBL18086149 0.80 ALOX5 (0.41) MAPTSMN1; SMN2ALOX5RAB9AALDH1A1
SCHEMBL19655290 0.79 HSD17B10 (0.34) MAPTSMN1; SMN2LMNAALOX5NPC1
SCHEMBL17809388 0.79 MAPT (0.38) MAPTLMNANPSR1ALOX5ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10840458-B2 Organic electroluminescent materials and devices UNIVERSAL DISPLAY CORPORATION (US) 2020-11-17 US disclosed
US-20170346022-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2017-11-30 US disclosed
US-20170346022-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2017-11-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170346022-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES PDXK, MT-ND4L, PNPO MAPT 2438/4885SMN1; SMN2 4815/4885NFKB1 4130/4885
US-10840458-B2 Organic electroluminescent materials and devices PDXK, MT-ND4L, PNPO MAPT 2438/4885SMN1; SMN2 4815/4885NFKB1 4130/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.